Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-24-023106
Filing Date
2024-02-29
Accepted
2024-02-29 16:16:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 february_2024_rdo-pipe_w.htm 424B5 492762
2 GRAPHIC img252204920_0.jpg GRAPHIC 8553
3 GRAPHIC img252204920_1.jpg GRAPHIC 5497
4 GRAPHIC img252204920_2.jpg GRAPHIC 5497
  Complete submission text file 0000950170-24-023106.txt   521386
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-261811 | Film No.: 24703873
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)